SAN903, a candidate therapy for idiopathic pulmonary fibrosis (IPF), led to a significant reduction in markers of inflammation and…
Articles by Patricia Inácio, PhD
More than half of the people with rare diseases and their caregivers, asked in a survey, were undecided or less…
The EveryLife Foundation for Rare Diseases is accepting applications for a scholarship program that aims to help adults with a…
At-home evaluation of lung function using a spirometry device is a “feasible and valid measure” for people with idiopathic…
During 2020, Pulmonary Fibrosis News held to its mission of providing daily coverage of breakthrough discoveries, promising therapies, clinical trials,…
Procalcitonin, a precursor of the calcitonin hormone, may be used as a potential biomarker of lung cancer…
Research investigating the role of immune cells in triggering lung and heart rejection following transplant will be supported by $10…
A gene therapy that lengthens the life of lung cells can halt scarring and help sustain lung regeneration in a…
Veracyte’s Envisia Genomic Classifier can aid in the diagnosis of idiopathic pulmonary fibrosis (IPF) and distinguish it from other…
Note: This story was updated Aug. 11, 2020, to correct the name of the factor involved in fibrosis to…